SLC5A2 and diabetic kidney disease: Another aspect of this is that while SGLT2 inhibitors were originally reported to specifically diminish the diabetic hyperfiltration of early diabetic nephropathy before anatomical injury to the glomerulus, they also exert preventative properties in more advanced diabetic nephropathy with segmental or global glomerulosclerosis.